GLP-1 Drugs Are Not Weight-Loss Shortcuts: Why Semaglutide Misuse Has Put India’s Regulators on Alert?
Semaglutide and tirzepatide change the way diabetes and obesity care treat diabetes and obesity with more efficient use, but misuse without prescribed use can be dangerous. This is how India is regulating GLP-1 drugs. Over the last several years, GLP-1 drugs like semaglutide have gone from diabetes clinics to social media chatter. What was initially […]
